New Era for Pharmaceutical Industry, INNOPHARMA CHINA CONGRESS 2011

INNOPHARMA CHINA CONGRESS 2011

Innovation Driven and Development with Transformation-New Era for Pharmaceutical Industry

 

The congress will be held on the 22^nd until the 23^rd of September, 2011 in Shanghai with plenary meetings and track sessions.  The InnoPharma China Congress 2011 organized by JFPS Group will gather more than 200 InnoPharma leaders and pioneers to bring the latest trends in the industry and will serve as a grand platform for face-to-face communication in tackling the drug discovery, clinical and regulatory issues in the industry.

 

The key topics that will be brought to light include:
  • Partnering & External Innovation
  • New Drug Research & Development, Preclinical & Clinical Development
  • Novel Therapeutics, Preclinical & Clinical Development
  • Creating Value Through Partnership

 

­­­­­­The pharma’s industry resilience has always been based on innovation--in science and in business modes. The convergence of new trends such as health care reform and the adoption of health information technology promises to change the very business that drug companies are in, from selling drugs to delivering outcomes.

 

A recent IMS Health Report pegged the pharmaceutical’s market annual growth rate at 27% from 2006-2009 and projected that China will surpass France and Germany to become the third-largest drug market in the world by 2011 (behind only the US and Japan).  Beyond the market opportunity, China remains a highly attractive outsourcing destination in terms of cost efficiency and, increasingly, patient availability for clinical trials, expertise and infrastructure.

 

Event at a glance

 

Thursday, September 22, 2011

Keynote Plenary Session
·         Challenges & Opportunities for drug innovation in China ·         MNC’s strategies for new drug R&D ·         Key factors to be successful in emerging pharmaceutical industry ·         Chinese government’s initiatives and investments in the 12th 5-year plan
New Drug Research & Development	Preclinical & Clinical Development
·  Novel drug abroad ·  Key New Drug Creation and Development Program ·  TCM ·  New uses of old drug ·  Panel Discussion	·  DMPK & ADME ·  Clinical pharmacology ·  DOE ·  CRO Corporation ·  Panel Discussion

 

Friday, September 23, 2011

Novel Therapeutics	Preclinical & Clinical Development
·  Oncology therapy ·  Therapeutic proteins ·  Antibody-based therapy ·  Human RNAi therapy ·  Gene Therapy and Stem Cell	·  Data management ·  Translational medicine &  biomarkers ·  Multicenter clinical trial ·  Clinical Bioinformatics in individualized Medicine ·  Panel Discussion
Plenary Session
·         Lead the way with the winning strategies, FIPNet ·         R&D outsourcing strategies and innovative partnering models ·         Driving clinical outsourcing to speed time to market through effective relationship management ·         Drug patent cliff and the evolution of IP valuation

For more information on the event, log on to http://innopharmachina.com/index.html 

 

Event Contact:

Grace.Jin

Executive, Marketing Communications

Tel: +86-21-51720154

E-mail: grace.jin@